AZX-1103

N/A

Report date: 2022/04/08 17:41:55

Base Information

Drug NameAZX-1103
Drug Alias NameAZX-1103
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionGastrointestinal microbiome modulatorsBeta Lactamase replacements
TargetsBeta Lactamase
Therapy Area/IndicationsCross Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEntero Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEntero Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCross Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A